GMABNasdaqPharmaceutical PreparationsAlso trades as GNMSF
GENMAB A/S
Financials through fiscal 2025, year ended Dec 31, 2025
$38.50+1.50 (+4.05%)
Close on Oct 19, 2026
Dividends
Genmab A/S has not reported a dividend
No dividend per share appears in Genmab A/S's annual filings since fiscal 2016.